U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Trafon Group, Inc. - 04/19/2017
  1. Warning Letters

CLOSEOUT LETTER

Trafon Group, Inc.

Recipient:
Trafon Group, Inc.

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA Logo

 

 

 
San Juan District
Compliance Branch
466 Avenida Fernández Juncos
San Juan, Puerto Rico 00901-3223
Tel: (787) 729-8500 

April 19, 2017

17-SJN-WLCOL-04

VIA UNITED PARCEL SERVICE
NEXT-DAY/SIGNATURE REQUIRED

Mr. Carlos A. Trapaga Fonalledas
CEO & President
Trafon Group, Inc.
Garden Hills Plaza PMB 342
#1353 Ave. Luis Vigoreaux
Guaynabo, Puerto Rico 00966-2718

Ref: 12-SJN-WL-05

Dear Mr. Trapaga Fonalledas:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 12-SJN-WL-05 dated 03/23/2012. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Kind regards,
/S/

Edwin Ramos
Director of Compliance Branch
San Juan District Office 

Back to Top